Perceptive Advisors LLC Iovance Biotherapeutics, Inc. Transaction History

Perceptive Advisors LLC

  • $3.46 Billion
  • Q2 2024

A detailed history of Perceptive Advisors LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 25,933,142 shares of IOVA stock, worth $249 Million. This represents 6.02% of its overall portfolio holdings.

Number of Shares
25,933,142
Previous 25,933,142 -0.0%
Holding current value
$249 Million
Previous $208 Million -0.0%
% of portfolio
6.02%
Previous 5.92%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$7.78 - $14.19 $51.8 Million - $94.5 Million
6,660,151 Added 34.56%
25,933,142 $208 Million
Q1 2024

May 15, 2024
BUY
$7.59 - $17.47 $55.4 Million - $127 Million
7,293,576 Added 60.88%
19,272,991 $286 Million
Q4 2023

Feb 14, 2024
BUY
$3.3 - $8.89 $54,374 - $146,480
16,477 Added 0.14%
11,979,415 $97.4 Million
Q3 2023

Nov 14, 2023
SELL
$4.44 - $8.79 $9.21 Million - $18.2 Million
-2,073,472 Reduced 14.77%
11,962,938 $54.4 Million
Q2 2023

Aug 14, 2023
SELL
$5.36 - $9.06 $6.99 Million - $11.8 Million
-1,303,325 Reduced 8.5%
14,036,410 $98.8 Million
Q1 2023

May 15, 2023
BUY
$5.53 - $8.22 $29.7 Million - $44.1 Million
5,367,955 Added 53.83%
15,339,735 $93.7 Million
Q4 2022

Feb 14, 2023
SELL
$5.62 - $10.0 $1.56 Million - $2.77 Million
-276,844 Reduced 2.7%
9,971,780 $63.7 Million
Q3 2022

Nov 14, 2022
SELL
$9.53 - $13.11 $15 Million - $20.7 Million
-1,577,675 Reduced 13.34%
10,248,624 $98.2 Million
Q2 2022

Aug 15, 2022
SELL
$6.38 - $18.33 $2.39 Million - $6.87 Million
-374,962 Reduced 3.07%
11,826,299 $131 Million
Q1 2022

May 16, 2022
BUY
$12.38 - $19.1 $25.7 Million - $39.6 Million
2,073,320 Added 20.47%
12,201,261 $203 Million
Q4 2021

Feb 14, 2022
SELL
$16.55 - $27.63 $22.5 Million - $37.6 Million
-1,361,831 Reduced 11.85%
10,127,941 $193 Million
Q3 2021

Nov 15, 2021
BUY
$20.35 - $26.63 $10.8 Million - $14.1 Million
530,000 Added 4.84%
11,489,772 $283 Million
Q2 2021

Aug 16, 2021
BUY
$16.33 - $33.07 $37.7 Million - $76.3 Million
2,307,987 Added 26.68%
10,959,772 $285 Million
Q1 2021

May 17, 2021
SELL
$28.67 - $52.59 $14.8 Million - $27.1 Million
-514,519 Reduced 5.61%
8,651,785 $274 Million
Q4 2020

Feb 16, 2021
SELL
$28.04 - $50.26 $25.8 Million - $46.2 Million
-919,328 Reduced 9.12%
9,166,304 $425 Million
Q3 2020

Nov 16, 2020
SELL
$27.75 - $36.3 $47.8 Million - $62.6 Million
-1,723,862 Reduced 14.6%
10,085,632 $332 Million
Q2 2020

Aug 14, 2020
BUY
$27.21 - $41.0 $3.79 Million - $5.72 Million
139,437 Added 1.19%
11,809,494 $324 Million
Q1 2020

May 15, 2020
BUY
$19.54 - $38.85 $44 Million - $87.6 Million
2,253,855 Added 23.94%
11,670,057 $349 Million
Q4 2019

Feb 14, 2020
SELL
$17.95 - $29.41 $28.7 Million - $47 Million
-1,598,500 Reduced 14.51%
9,416,202 $261 Million
Q3 2019

Nov 14, 2019
SELL
$17.99 - $26.0 $16.2 Million - $23.4 Million
-900,425 Reduced 7.56%
11,014,702 $200 Million
Q2 2019

Aug 14, 2019
SELL
$9.78 - $24.52 $3.14 Million - $7.86 Million
-320,684 Reduced 2.62%
11,915,127 $292 Million
Q1 2019

May 15, 2019
SELL
$8.41 - $11.26 $44,573 - $59,678
-5,300 Reduced 0.04%
12,235,811 $116 Million
Q4 2018

Feb 14, 2019
BUY
$7.51 - $11.93 $37.2 Million - $59.1 Million
4,950,912 Added 67.91%
12,241,111 $108 Million
Q3 2018

Nov 14, 2018
BUY
$11.25 - $17.7 $16.2 Million - $25.5 Million
1,437,997 Added 24.57%
7,290,199 $82 Million
Q2 2018

Aug 14, 2018
SELL
$12.45 - $16.95 $3.86 Million - $5.25 Million
-310,000 Reduced 5.03%
5,852,202 $74.9 Million
Q1 2018

May 15, 2018
BUY
$8.1 - $19.5 $11.2 Million - $27 Million
1,386,088 Added 29.02%
6,162,202 $104 Million
Q4 2017

Feb 14, 2018
BUY
$6.65 - $9.25 $332,500 - $462,500
50,000 Added 1.06%
4,776,114 $38.2 Million
Q3 2017

Nov 14, 2017
BUY
$4.45 - $8.55 $21 Million - $40.4 Million
4,726,114
4,726,114 $36.6 Million

Others Institutions Holding IOVA

# of Institutions
323
Shares Held
239M
Call Options Held
1.27M
Put Options Held
1.68M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.52B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email